Quick Verdict
ACE-031
Risk
Half-life
~14 days
AICAR
Risk
Half-life
—
Side-by-Side Comparison
About ACE-031
Soluble decoy receptor for ActRIIB; sequesters myostatin, activin, and GDF-11 to remove multiple brakes on muscle and bone growth simultaneously
A soluble decoy receptor that blocks the ActRIIB pathway, inhibiting myostatin and related TGF-β family proteins. Produces dramatic muscle and bone gains but carries cardiovascular risks at high doses.
Research Areas
About AICAR
Converted intracellularly to ZMP, a potent AMPK activator. AMPK activation increases fatty acid oxidation, glucose uptake, and mitochondrial biogenesis — the same metabolic pathways activated by sustained aerobic exercise.
A cell-permeable nucleoside analog that activates AMPK, mimicking cellular exercise signals. Studied for endurance enhancement and metabolic disease research. Not a true peptide — a synthetic nucleoside frequently sold by peptide vendors.
Research Areas
Find Providers
Where to source these peptides
Providers offering
ACE-031
2 listed
Browse directory →
Providers offering
AICAR
3 listed
Browse directory →
PeptideBase lists providers for educational research purposes only. Always consult a qualified healthcare professional before obtaining or using any peptide.
More performance Comparisons
Browse all peptides →Educational research tools — not medical advice.